BACKGROUND: Both the immediate beneficial physiological changes in a laboratory setting and the long-term clinical outcomes of heat and moisture exchanger (HME) use are well described. So far, there has not been any research published that provides detailed insight in the pattern of changes in both respiratory function and patients' experiences with HMEs in the first weeks of use. METHODS: A multicenter time-series study design with a 2-week double baseline period. All patients used the XtraHME for 12 weeks afterward. Data were collected 2 weeks, 6 weeks, and 12 weeks after the start of HME use. RESULTS: Data of 30 patients were analyzed. Pulmonary symptoms decreased significantly during the 12 weeks of HME use. After 2 weeks, a significant decrease in daily coughs and daily forced expectorations was seen. The general quality of life showed a significant increase throughout the study. More general physical complaints also significantly decreased with HME use. Patient satisfaction with the HME was high. CONCLUSIONS: This study shows that there is a significant influence of the XtraHME on pulmonary status that can already be observed after 2 weeks of using the XtraHME and continues to improve further after 6 weeks of XtraHME use.
BACKGROUND: Both the immediate beneficial physiological changes in a laboratory setting and the long-term clinical outcomes of heat and moisture exchanger (HME) use are well described. So far, there has not been any research published that provides detailed insight in the pattern of changes in both respiratory function and patients' experiences with HMEs in the first weeks of use. METHODS: A multicenter time-series study design with a 2-week double baseline period. All patients used the XtraHME for 12 weeks afterward. Data were collected 2 weeks, 6 weeks, and 12 weeks after the start of HME use. RESULTS: Data of 30 patients were analyzed. Pulmonary symptoms decreased significantly during the 12 weeks of HME use. After 2 weeks, a significant decrease in daily coughs and daily forced expectorations was seen. The general quality of life showed a significant increase throughout the study. More general physical complaints also significantly decreased with HME use. Patient satisfaction with the HME was high. CONCLUSIONS: This study shows that there is a significant influence of the XtraHME on pulmonary status that can already be observed after 2 weeks of using the XtraHME and continues to improve further after 6 weeks of XtraHME use.
Authors: Valesca P Retèl; Cindy van den Boer; Lotte M G Steuten; Sławomir Okła; Frans J Hilgers; Michiel W van den Brekel Journal: Eur Arch Otorhinolaryngol Date: 2015-04-02 Impact factor: 2.503
Authors: Barbara Ebersole; Kathleen Moran; Jiangtao Gou; John Ridge; Linda Schiech; Jeffrey C Liu; Miriam Lango Journal: Head Neck Date: 2020-05-23 Impact factor: 3.147
Authors: Andy Bertolin; Marco Lionello; Valentina de Robertis; Francesco Barbara; Francesco Cariti; Michele Barbara Journal: Acta Otorhinolaryngol Ital Date: 2022-04 Impact factor: 2.618
Authors: L Lansaat; B J de Kleijn; F J M Hilgers; B F A M van der Laan; M W M van den Brekel Journal: Eur Arch Otorhinolaryngol Date: 2016-09-14 Impact factor: 2.503
Authors: Chathura B B Ratnayake; Renske Fles; I Bing Tan; Laura W J Baijens; Walmari Pilz; Cees A Meeuwis; Pauline H E Janssen-van Det; Rob van Son; Michiel W M Van den Brekel Journal: Laryngoscope Date: 2019-02-20 Impact factor: 3.325
Authors: Liset Lansaat; Bertram de Kleijn; Frans Hilgers; Bernard van der Laan; Michiel van den Brekel Journal: Int Arch Otorhinolaryngol Date: 2017-06-16